IL17A and bullous pemphigoid: In patients with bullous pemphigoid, monocyte-derived macrophages, but not lymphocytes, respond to CXCL10 (upregulated by IL-17) by increasing MMP-9 release, potentially creating an inflammatory loop associated with disease outcome (71).